Is a second look necessary in multiple and/or large Ta tumors?
Submitted: October 4, 2015
Accepted: December 4, 2015
Published: July 4, 2016
Accepted: December 4, 2015
Abstract Views: 1309
PDF: 893
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Roberto Giulianelli, Barbara Cristina Gentile, Gabriella Mirabile, Luca Albanesi, Paola Tariciotti, Giorgio Rizzo, Maurizio Buscarini, Mauro Vermiglio, Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience , Archivio Italiano di Urologia e Andrologia: Vol. 89 No. 4 (2017)
- Khaled Al-Kohlany, Khaled Baker, Faisal Ahmed, Murtadha Mohamed, Majdi Alshami, Mohamed Badheeb, Treatment outcome of Fournier's gangrene and its associated factors: A retrospective study , Archivio Italiano di Urologia e Andrologia: Vol. 95 No. 2 (2023)
- Saif Ghabisha, Faisal Ahmed, Saleh Al-wageeh, Mohamed Badheeb, Qasem Alyhari, Abdulfattah Altam, Afaf Alsharif, Prognostic determinants and treatment outcomes of Fournier’s Gangrene treatment in a resource-limited setting: A retrospective study , Archivio Italiano di Urologia e Andrologia: Vol. 95 No. 3 (2023)
You may also start an advanced similarity search for this article.